C

Centrus Energy Corp
F:4CU

Watchlist Manager
Centrus Energy Corp
F:4CU
Watchlist
Price: 260.4 EUR 8.68% Market Closed
Market Cap: €4.2B

Centrus Energy Corp
Investor Relations

Centrus Energy Corp., a company overlooked by many outside the niche of nuclear energy, stands as a critical player in the complex world of uranium enrichment. Long rooted in the legacy of governmental atomic development, Centrus was set free to sail into the seas of the private sector with its public listing. The company primarily caters to utilities engaged in nuclear power generation through the production and supply of enriched uranium. With a keen focus on the future of energy needs, Centrus utilizes advanced technology to meet the stringent requirements for nuclear fuel. This is crucial as many nations look to reduce their carbon footprints while keeping their energy grids robust.

Through the intricate and technically demanding process of uranium enrichment, Centrus Energy finds its primary revenue stream. The product it delivers, Enriched Uranium Product (EUP), plays a vital role in the global quest for sustainable energy. Working to diversify and modernize its capabilities, Centrus has embraced new innovation paths like the AC-100M centrifuge. By doing so, they ensure consistent efficiency in uranium enrichment, aligning with both current demands and future aspirations of nuclear energy advancements. As economies seek stable and low-carbon energy solutions, Centrus Energy Corp.’s strategic maneuvers in technology and supply chain positions it well to serve as a linchpin in this evolving energy narrative.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 6, 2025
AI Summary
Q3 2025

Revenue Growth: Centrus Energy reported third quarter revenue of $74.9 million, up 30% year-over-year.

Profit Rebound: Net income was $3.9 million for the quarter, reversing a net loss of $5 million in the same period last year.

Capital Actions: The company closed an $805 million convertible note offering and launched a $1 billion at-the-market equity program to strengthen its balance sheet.

Strong Backlog: Total company backlog reached $3.9 billion, with significant commitments extending to 2040.

Market Opportunity: Management highlighted surging demand for nuclear fuel, with SWU spot prices rising to $220 and new customer and partnership momentum.

Operational Progress: Centrus celebrated two years of continuous operation of its HALEU enrichment cascade and ongoing supply chain readiness efforts.

Key Financials
Revenue
$74.9 million
Net Income
$3.9 million
Year-to-Date Net Income
$60 million
Gross Loss
$4.3 million
Operating Loss
$16.6 million
LEU Segment Revenue
$44.8 million
Technical Solutions Segment Revenue
$30.1 million
LEU Segment Cost of Sales
$52.6 million
CTS Segment Cost of Sales
$26.6 million
Company Backlog
$3.9 billion
LEU Segment Backlog
$3 billion
Technical Solutions Segment Backlog
$0.9 billion
Convertible Senior Notes Issued
$805 million
Proceeds from Convertible Notes
$782.4 million
Unrestricted Cash Balance
over $1.6 billion
At-the-Market Equity Program
$1 billion
SWU Spot Price
$220
HALEU Cascade Machine Hours
over 3.9 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Kevin J. Harrill
Senior VP, CFO, Treasurer, Controller & Chief Accounting Officer
No Bio Available
Mr. Shahram Ghasemian
Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary
No Bio Available
Mr. John M. A. Donelson
Senior VP & Chief Marketing Officer
No Bio Available
Mr. Larry B. Cutlip
Senior VP of Field Operations & President of American Centrifuge Operating, LLC
No Bio Available
Mr. Amir V. Vexler
President, CEO & Director
No Bio Available
Mr. Neal Nagarajan
Senior VP & Head of Investor Relations
No Bio Available
Mr. Dan Leistikow
Vice President of Corporate Communications
No Bio Available
Mr. Richard V. Rowland
VP & Chief Human Resource Officer
No Bio Available
Mr. Andrew Ginsburg
Associate Director
No Bio Available

Contacts

Address
MARYLAND
Bethesda
6901 Rockledge Dr, Suite 800
Contacts